Shares of 180 Life Sciences Corp (NASDAQ: ATNF), soon to be rebranded as ETHZilla, continued their upward trajectory with a 15.92% surge in pre-market trading on Wednesday. This latest jump follows a series of significant announcements that have dramatically reshaped the company's strategic direction and investor perception.

The biotechnology company's stock price rally is primarily driven by several key developments: 1. ATNF announced a massive purchase of approximately $350 million worth of Ethereum, signaling a major shift towards cryptocurrency investments. 2. Billionaire Peter Thiel and his investment team have acquired a 7.5% stake in the company, as revealed in a recent SEC filing. 3. The company unveiled plans to rebrand as ETHZilla, positioning itself as an Ethereum treasury reserve company. 4. ATNF completed a $156 million private offering to further boost its Ethereum reserves.

This strategic pivot towards becoming an Ethereum-focused investment vehicle has clearly resonated with investors. The involvement of high-profile tech investor Peter Thiel lends significant credibility to the company's new direction, while the substantial Ethereum holdings provide a tangible asset base that aligns with growing interest in cryptocurrency investments. As the crypto market continues to evolve and institutional interest in digital assets grows, ATNF's transformation into ETHZilla positions it uniquely in the public markets, potentially capturing value from Ethereum's future growth and adoption.